Soterix Medical Inc.

237 West 35th Street, 1401, 10001 New York
United States of America
Telephone +1 917 809-9260
Fax +1 212 315-3232
contact@soterixmedical.com
http://www.soterixmedical.com

Product Categories

01 Electromedical equipment / Medical Technology
01.03 Therapie and physical medicine
01.03.02 Electro-therapy equipment
MEDICA 2017
Electro-therapy equipment

HD-Explore™ 4.0 with tDCS emulation
HD-Targets™
Remote Neuromodulation Systems
transcutaneous Spinal Direct Current Stimulation
Galvanic Vestibular Stimulation
5 Products

ad: contact information

Company

Company details
Soterix Medical Inc. (SMI) was formed to develop and deploy innovative medical treatments focused on neuropsychiatric and neurological disorders and rehabilitation. Founded in 2008, SMI is the world leader in clinical trials for non-invasive neuromodulation working with over 250 medical centers in the US and worldwide. SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), Limited Total Energy tDCS (LTE-tDCS), and Neurotargeting. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. Ongoing Phase I, II, IIb, and III trials use investigational devices that are regulated/limited by US or Federal law. SMI is proudly based in New York City with international distributors in all major markets.

ad: contact information